Crizotinib, obat baru anti kanker paru
Crizotinib
![crizotinib crizotinib](http://topnews.in/health/files/lung-cancer-symptoms.jpg)
crizotinib
On August 26, 2011, the U. S. Food and Drug Administration granted accelerated approval to crizotinib (XALKORI
![crizotinib crizotinib](http://portal.acs.org/portal/binfetch/consumption?fileUrl=/stellent/groups/web/documents/article/%7Eexport/CNBP_025954%7E2%7EHTML_DC_TEMPLATE%7ESNIPPET_LAYOUT/27377-1.jpg)
crizotinib
Capsules, Pfizer Inc.) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. The FDA approved the Vysis ALK Break-Apart FISH Probe Kit (Abbott Molecular, Inc.) concurrently with the crizotinib approval. This companion diagnostic test is designed to detect rearrangements of the anaplastic lymphoma kinase (ALK) gene in NSCLC.